VEGFA and cholangiocarcinoma: Recent studies have indicated that dysfunctional ECs upregulate vascular endothelial growth factor (VEGF) and syndecan-1 in the tumor stroma, thereby promoting angiogenesis and stimulating migration, epithelial to mesenchymal transition (EMT), and cholangiocarcinoma cell invasion4,5.